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PCardiomyopathy
Predictors of Complete Heart Block After
Transcoronary Ablation of Septal Hypertrophy
Results of a Prospective Electrophysiological Investigation
in 172 Patients With Hypertrophic Obstructive Cardiomyopathy
Thorsten Lawrenz, MD,* Frank Lieder, MD,† Markus Bartelsmeier, MD,* Christian Leuner, MD,*
Bianca Borchert, MD,* Dorothee Meyer zu Vilsendorf, MD,* Claudia Strunk-Mueller, MD,*
Jens Reinhardt, MD,* Andre Feuchtl, MD,* Christoph Stellbrink, MD, FACC,*
Horst Kuhn, MD, FESC*
Bielefeld and Muenster, Germany
Objectives This study analyzed changes in intracardiac conduction during transcoronary ablation of septal hypertrophy
(TASH) to identify predictors for pacemaker dependency after TASH.
Background Transcoronary ablation of septal hypertrophy is an accepted therapeutic option in hypertrophic obstructive car-
diomyopathy (HOCM). However, atrioventricular conduction disorders, requiring permanent pacemaker implanta-
tion, remain a major adverse effect.
Methods This study measured changes in intracardiac conduction in 172 consecutive patients during TASH by simulta-
neously recording electrophysiological parameters and correlated these parameters with the occurrence of com-
plete heart block during continuous electrocardiographic monitoring for 8 days.
Results Intraprocedural complete heart block occurred in 36 patients (20.1%) and was associated with a pre-existing
bundle branch block (p  0.010) or advanced age (p  0.023). All patients with delayed complete heart block
during follow-up (n  15, 8.7%), occurring 1 to 6 days after TASH, showed lack of retrograde atrioventricular
nodal conduction after TASH (p  0.018). None of the patients with intact retrograde conduction after TASH de-
veloped delayed complete heart block. Further risk factors for delayed block were advanced age, intraprocedural
complete heart block, and prolonged QRS duration before or after TASH (p  0.05 for all). Permanent pace-
maker implantation was performed in 20 patients.
Conclusions Measurement of intracardiac conduction during TASH improves the safety of the procedure by enabling identifi-
cation of patients who are at risk of complete heart block after TASH. The duration of prophylactic temporary
pacemaker backup should be prolonged up to day 6 after TASH in patients at increased risk (patients with retro-
grade atrioventricular block and at least 1 additional risk factor). (J Am Coll Cardiol 2007;49:2356–63)
© 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.02.056H
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hranscoronary alcohol ablation of septal hypertrophy (TASH)
s a therapeutic catheter-based option and an alternative to
urgery in the treatment of patients with hypertrophic
bstructive cardiomyopathy (HOCM) (1–11). The safety of
he procedure has been improved considerably by reducing
he amount of ethanol injected into the appropriate septal
ranch of the left anterior descending coronary artery (1–5).
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are, Bielefeld, Germany; and †Raphaelsklinik Muenster GmbH, Medical Clinic I,
uenster, Germany. This study was supported in part by a grant from the Franz
oogen Foundation, Düsseldorf, Germany.m
Manuscript received October 31, 2006; revised manuscript received January 29,
007, accepted February 20, 2007.owever, delayed in-hospital sudden unexpected complete
eart block after an uncomplicated intervention remains a
ajor complication (1,2). It is yet unclear how pacemaker
ependency after TASH can be predicted. The onset of
elayed complete heart block may occur up to several days
fter an uncomplicated TASH procedure (1,2). Therefore,
elemetric monitoring for 8 days is recommended by some
roups (10). In the present study, we sought to analyze
hanges in intracardiac conduction during TASH by simul-
aneously recording electrophysiological parameters and
orrelated these parameters with the occurrence of complete
eart block during continuous electrocardiographic (ECG)
onitoring for 8 days.
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June 19, 2007:2356–63 Predictors of Complete Heart Block After TASHethods
atients. We enrolled 172 consecutive patients with
OCM in the study. All patients gave their written consent
o the study. Patient characteristics are shown in Table 1.
ll patients suffered from severe symptoms caused by
OCM despite oral medication.
ASH procedure. We used titrated coronary flow and
radient-adapted ethanol injection aiming for at least 50%
radient reduction at rest and after provocation with pro-
rammed extrasystolic right ventricular stimulation (1,5–
1). Continuous monitoring of the left ventricular outflow
ract gradient was performed by a pigtail catheter placed in
he apex of the left ventricle and a coronary catheter placed
n the ascending aorta. Programmed stimulation with 1
xtrasystole at 380 ms (every 7th beat) was used for gradient
rovocation. In addition, temporary pacemaker backup is
ecommended during and after the session. Therefore, 2
acemaker catheters were inserted in the right ventricle (1
or pacemaker backup and 1 for gradient provocation).
efore injecting ethanol, a selective angiography of the
eptal coronary branch was performed to visualize the target
rea in the septum, to exclude backflow in the left anterior
escending artery, and to estimate the efficacy of the
elected vessel regarding gradient reduction (ischemic effect
f balloon occlusion and contrast medium). A target vessel
as selected for ethanol injection, in case the selective
ontrast medium injection led to a significant reduction of
bstruction (at least 25% gradient reduction). Intravenous
edation with 5.2  2 mg diazepam (maximum 20 mg) and
5.3  5 mg pethidine (maximum 50 mg) and body
eight-adjusted intravenous injections of heparin (100 IU/
g) were administered at the beginning of the therapeutic
ession.
ntracardiac recordings. Intracardiac recordings were ob-
ained by using the 2 electrophysiology (EP) catheters that
re routinely recommended during TASH in our center (2).
ll parameters were measured at baseline and at the end of
he session. Intravenous sedation was administered before
he first measurement. A 5-F EP bipolar catheter was
laced in the right ventricular apex via the femoral route. A
econd quadripolar catheter was then placed in the right
trium. Incremental atrial and ventricular pacing was per-
ormed by using either the atrial or the ventricular catheter
eginning with a cycle length of 1,000 ms to determine the
eat-to-beat interval with atrioventricular (AV) nodal
enckebach block (antegrade and retrograde). Retrograde
V nodal block was defined as block of conduction to the
trium at a cycle length 10 ms shorter than the intrinsic rate.
he atrial catheter was then used for His bundle recordings.
he atrium-to-proximal-His (AH) and the distal-His-to-
entricle (HV) intervals were measured at baseline and at
he end of the session. The AH interval was defined as the
ime interval between the atrial and the proximal His
otential in the His bundle electrogram. The HV interval
as defined as the time interval between the proximal His cotential in the His bundle elec-
rogram and the earliest onset of
he R-wave in the surface electro-
ram. During the therapeutic ses-
ion, the atrial catheter was moved
o the ventricle for gradient prov-
cation (see TASH procedure).
urface ECG criteria. The PR
nterval and the QRS interval were
easured at baseline and at the
nd of the session. A QRS interval
rolongation of at least 120 ms was
efined as bundle branch block.
ontinuous ECG monitoring.
fter the procedure, all patients were supervised in the
ntensive care unit for 24 h with a temporary pacemaker lead
n the right ventricle. Continuous telemetric monitoring
as extended up to day 8 in all patients. Two patients with
primary preventive implantable defibrillator before TASH
eceived telemetric monitoring for 24 h only. In these
atients, detection of complete heart block was performed
y interrogation of the device after 8 days.
efinition of complete heart block. Complete heart block
as defined as third-degree AV block of at least 10 s
uration. Intraprocedural third-degree AV block was de-
ned as complete heart block occurring during the TASH
rocedure, and delayed third-degree AV block was defined
s complete heart block observed after the intervention (up
o day 8).
tatistics. Commercial software (SPSS version 10, SPSS
nc., Chicago, Illinois) was used for statistical analysis. The
ssociation between the occurrence of complete heart block
nd the presence of conduction delay was tested using the
tudent t test for continuous variables with normal distri-
ution or the Mann-Whitney U test for continuous vari-
bles without normal distribution. The association between
he occurrence of complete heart block and not continuous
ariables was tested using the chi-square test. Parameters
hat were significantly correlated with complete heart block
ere entered stepwise in one multivariate logistic regression
odel to analyze the predictive power of each parameter.
alues are expressed by the mean SD. Values of p 0.05
ere considered statistically significant.
esults
ASH procedure. The TASH procedure was successfully
erformed in 169 of the 172 patients (success rate 98.2%;
.90  0.3 ml ethanol was injected in 1 or 2 side branches
f the most proximal septal perforator of the left anterior
escending coronary artery, leading to a significant reduc-
ion of the intraventricular gradients at rest and after
rovocation (p  0.0001) (Table 1). No patient died during
he hospital stay. Among the patients with ineffective
reatment (gradient reduction 50% at rest or after provo-
Abbreviations
and Acronyms
AH  atrium-to-proximal-His
AV  atrioventricular
ECG  electrocardiographic
EP  electrophysiology
HOCM  hypertrophic
obstructive cardiomyopathy
HV  distal-His-to-ventricle
TASH  transcoronary
ablation of septal
hypertrophyation despite ethanol injection), 2 patients underwent
Patient Characteristics and Electrophysiological Findings of the Whole Study Population and of Patients With or Without Complete Heart Block
Table 1 Patient Characteristics and Electrophysiological Findings of the Whole Study Population and of Patients With or Without Complete Heart Block
All Patients
No Intraprocedural
Complete Heart Block
Intraprocedural
Complete Heart Block
No Delayed
Complete Heart Block
Delayed
Complete Heart Block
Number of patients 172 136 36 157 15
Age (yrs) 57.4 15 55.89 15.7 62.5 12.8* 56.5 15 66.3 13*
LV outflow gradient, mean mm Hg
Before TASH at rest (mm Hg) (provocation†) 69.8 42 (158.5 59) 66.8 40.9 (154.3 55) 75.9 42 (173.1 69) 68.6 42 (154.8 53) 82.9 46 (197.9 97)
After TASH at rest (mm Hg) (provocation†) 22.9 38 (64.0 46) 23.4 43 (62.3 46) 21.1 17 (65.7 46) 22.8 39 (64.0 47) 24.2 21 (64.2 42)
Maximum creatine kinase activity after TASH (U/l) 640.2 336 674.1 371.9 530.7 168.3 629.9 319.1 803.8 570.5
Amount of ethanol, ml 0.85 0.9 0.8 0.80 1.05
Median [interquartile 25th–75th] [0.6–1.2] [0.6–1.2] [0.6–1.2] [0.6–1.2] [0.8–1.2]
Ineffective TASH, n (%) 3 (1.7) 3 (2.2) 0 (0) 3 (1.9) 0 (0)
Pacemaker implantation after TASH, n (%) 20 (12) 12 (9) 5 (14) 5 (3) 15 (100)
Bundle branch block before TASH, n (%) 33 (19) 20 (19) 13 (37)* 29 (18) 4 (27)
Bundle branch block after TASH, n (%) 88 (51) 65 (47) 20* (55) 77 (49) 11 (73)
AV nodal Wenckebach point before TASH
(after TASH), ms
390.3 95 (474.5 118) 389.6 96 (473.4 124) 397.0 94 (484.2 77) 391.6 93 (476.9 119) 376.0 118 (442.8 97)
Retrograde block before TASH, n (%) 60 (35) 48 (35) 11 (30) 52 (33 ) 8 (53)
Retrograde block after TASH, n (%) 96 (56) 72 (53) 23 (64) 82 (52) 15 (100)*
Heart rate at baseline (after TASH), beats/min 75.8 11 (72.3 13) 74.7 13 (73.7 12) 73.1 11 (71.1 11) 75.0 12 (76.1 18) 76.4 11 (74.8 13)
Intraprocedural complete heart block, n (%) 36 (21) 36 (100) 29 (18) 7 (47)*
PR interval before TASH (after TASH), ms 178.5 36 (196.0 45) 177.2 36 (192.1 40.8) 183.6 37 (217.4 58)‡ 178.4 37 (196.0 45) 179.6 28 (196.3 56)
QRS interval before TASH (after TASH), ms 107.4 22 (131.1 27) 104.9 19 (128.1 27) 117.7 28* (141.9 24)* 106.3 22 (129.8 28) 119.6 20* (146.2 19)*
AH interval before TASH (after TASH), ms 93.3 29 (107.3 35) 93.2 29 (107.4 37) 95.1 30 (110.4 29) 93.7 29 (107.8 36) 88.6 24 (101.8 26)
HV interval before TASH (after TASH), ms 45 [40–55] 45 [40–50] 50 [45–60]‡ 45 [40–55] 55 [45–64]
Median [interquartile 25th–75th] (55 [45–65]) (50 [45–60]) (65 [52–72])* (45 [40–55]) (55 [40–65])
Values are mean  SD or n (%). *p  0.05. †Provocation  postextrasystolic gradient. ‡p  0.07.
AH  atrium-to-proximal-His; AV  atrioventricular; HV  distal-His-to-ventricle; LV  left ventricular; TASH  transcoronary ablation of septal hypertrophy.
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June 19, 2007:2356–63 Predictors of Complete Heart Block After TASHurgical myectomy and 1 underwent dual-chamber pacing.
n 11 patients (6.3%), the TASH procedure was a repeat
ntervention because of ineffective or only partially effective
reatment results at 6-month follow-up.
nfluence of TASH on intracardiac conduction. Various
atterns of conduction disorders during the TASH proce-
ure were noticed. Overall significant prolongation of all
easured parameters was observed (Fig. 1): QRS interval
as the parameter with the most pronounced change (23%
rolongation), followed by antegrade AV nodal Wenck-
bach point (22% prolongation), AH interval (15% prolon-
ation), HV interval (15% prolongation), and PR interval
7% prolongation). The percentage of patients with bundle
ranch block was 54% after TASH (baseline 11%), 42%
ith right and 12% with left bundle branch block (Fig. 2).
ack of retrograde AV nodal conduction was present in 60
atients (34%) at baseline and in 96 patients (56%) after
ASH (Fig. 1). No patient with pre-existing retrograde AV
lock showed recovery of VA conduction after ethanol
blation.
omplete heart block. Intraprocedural complete heart
lock occurred in 36 patients (21%). In 15 of 36 patients, we
ere able to perform continuous recording of the His
undle ECG during the onset of complete heart block
howing intra-His or infra-His block in 14 of 15 patients
Fig. 3). In only 1 patient, we observed a supra-His block
uring the onset of third-degree AV block. The duration of
ntraprocedural complete heart block varied from 10 s to
h. Delayed complete heart block occurred in 15 patients
8.7%) at a mean time of 74.5  38.4 h (range 1 to 6 days)
fter TASH (Fig. 4). The duration of delayed complete
Figure 1 Changes in Intracardiac Conduction During TASH
Changes in intracardiac conduction before (ruled bars) and after TASH (open
bars). AH  atrium-to-proximal-His; AV  atrioventricular; AVN  atrioventricu-
lar node; HV  distal-His-to-ventricle; TASH  transcoronary ablation of septal
hypertrophy; WP ante  antegrade Wenckebach point.seart block varied from 10 s to 4 h (mean 5.6  3 min). Of
he 15 patients with delayed complete heart block, 13 had
ecurrent episodes (mean 3.2 1). All patients with delayed
omplete heart block received permanent dual chamber
acemaker implantation. In 5 patients, pacemaker implan-
ation was performed after persistent intraprocedural com-
lete heart block for more than 2 h after TASH.
ssociation between complete heart block and conduc-
ion disturbances. INTRAPROCEDURAL COMPLETE HEART
LOCK. In patients with intraprocedural complete heart
lock, we measured higher levels in most of the parameters
ompared with patients with unimpaired AV nodal conduc-
ion, however, not in the maximal creatine kinase activity
alues after TASH and not in the average amount of
thanol (Table 1).
Patients with intraprocedural complete heart block were
Figure 2 Prevalence of BBB
Occurrence of bundle branch block (BBB) before (upper panel) and after TASH
(lower panel). LBB  left bundle branch; RBB  right bundle branch; TASH 
transcoronary ablation of septal hypertrophy.ignificantly older (62.5 years vs. 55.9 years, p  0.025) and
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Predictors of Complete Heart Block After TASH June 19, 2007:2356–63ad a prolonged QRS interval before TASH (117.7 ms vs.
04.9 ms, p  0.017). In addition, there was a trend toward
more prolonged HV interval (50.7 ms vs. 47.2 ms, p 
.056). At the end of the session, the patients with third-
egree heart block during the procedure showed a signifi-
ant prolongation of the PR interval (217.4 ms vs. 192.1 ms,
 0.060), QRS interval (141.9 ms vs. 128.2 ms, p 
.026), and HV interval (70.0 ms vs. 53.8 ms, p  0.001).
pre-existing left bundle branch block was associated with
he occurrence of intraprocedural complete heart block (p
Figure 3 Intraprocedural Complete Heart Block
Example of the development of intraprocedural complete heart block. Intracar-
diac His bundle ECG and surface ECG during TASH. (Left) Absence of complete
heart block immediately before ethanol injection. (Right) Infra-His block after
ethanol injection. Sinus rhythm was restored spontaneously after 5 min in this
patient. A  atrial potential; ECG  electrocardiogram; His  His potential;
TASH  transcoronary ablation of septal hypertrophy; V  ventricular potential.
Figure 4 Time Distribution of Delayed Complete Heart Block
Time distribution of delayed complete heart block
after transcoronary ablation of septal hypertrophy (TASH).T.013) as well as a pre-existing right bundle branch block
p  0.044). Positive and negative predictive values and the
ensitivity and specificity of the parameters regarding the
isk of intraprocedural third-degree AV block are shown in
able 2. Positive predictive values of the parameters, which
ere associated with intraprocedural complete heart block,
ere low, but negative predictive values were 80%.
ELAYED COMPLETE HEART BLOCK. Patients who experi-
nced delayed complete heart block were significantly older
ompared with patients without complete heart block (66.3
ears vs. 55.5 years, p  0.013). The QRS duration was
ignificantly prolonged at baseline (119.6 ms vs. 106.3 ms,
 0.014) and after TASH (146.2 ms vs. 129.8 ms, p 
.029) in this patient group. Retrograde AV nodal block
fter TASH (assessed by incremental ventricular pacing)
as noticeable in all patients with delayed complete heart
lock, but in only 56% of the subset without complete heart
lock during follow-up (p  0.003). Patients with intact
etrograde conduction at baseline and retrograde block after
ASH had no higher risk of pacemaker dependency com-
ared with patients with a pre-existing retrograde AV block.
ensitivity, Specificity, Positive Predictive Value,nd Negative Predic ive Value of the Parametershat Were Significantly Associated Wi h theccurrence of Complet Heart Block After TASH
Table 2
Sensitivity, Specificity, Positive Predictive Value,
and Negative Predictive Value of the Parameters
That Were Significantly Associated With the
Occurrence of Complete Heart Block After TASH
Parameter
Intraprocedural
Complete Heart Block
(%)
Delayed
Complete Heart Block
(%)
Intraprocedural complete
heart block
Sensitivity 47
Specificity 76
Positive predictive value 19
Negative predictive value 93
Retrograde AV nodal block
after TASH
Sensitivity 100
Specificity 31
Positive predictive value 16
Negative predictive value 100
Age58 yrs
Sensitivity 65 73
Specificity 51 51
Positive predictive value 29 14
Negative predictive value 83 95
QRS120 ms before TASH
Sensitivity 36 27
Specificity 82 77
Positive predictive value 39 12
Negative predictive value 82 92
QRS120 ms after TASH
Sensitivity 53 73
Specificity 40 39
Positive predictive value 23 13
Negative predictive value 88 98
bbreviations as in Table 1.he percentage of patients with intraprocedural complete
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June 19, 2007:2356–63 Predictors of Complete Heart Block After TASHeart block was significantly higher in the group with
elayed block (47%) compared with the patient group
ithout delayed block (18%, p  0.023). In the subset of
atients with delayed complete heart block, maximal crea-
ine kinase release after TASH tended to be higher (804 vs.
30 U/l), although this was no statistically significant (Table
). The amount of ethanol was no different in the subgroups
ith delayed third-degree AV block or no complete heart
lock (Table 1). There were no significant correlations
etween the cycle length of antegrade or retrograde Wenck-
bach block and delayed complete heart block. Prolongation
f the cycle lengths of Wenckebach block (value after minus
alue before block) did not significantly correlate with
omplete heart block. Positive and negative predictive values
nd sensitivity and specificity of the parameters are shown in
able 2. All parameters that were associated with delayed
omplete heart block were characterized by a low positive
nd a high negative predictive value. The negative predictive
alue of retrograde AV nodal block after TASH was 100%.
o study the predictive power of the parameters that were
ignificantly associated with delayed total heart block, we
erformed a logistic regression analysis. After including all 4
arameters in 1 regression model, retrograde AV block after
ASH and age had the strongest predictive power (p 
.002, odds ratio  1.059; p  0.040, odds ratio  1.005)
egarding the occurrence of delayed complete heart block.
he QRS interval after TASH and intraprocedural com-
lete heart block, although significantly correlated with
elayed complete heart block, did not improve the predic-
ive power.
None of the patients without any risk factors developed
elayed complete heart block during follow-up. Patients
ith a single risk factor had a 3.5% risk of delayed complete
eart block (2 risk factors, 16%; 3 risk factors, 16%; 4 risk
actors, 33%). Patients with retrograde AV block after
ASH and at least 1 additional risk factor had a 26% risk of
omplete heart block.
-month follow-up. MORTALITY. After 6 months, 3 pa-
ients had died, resulting in a mortality of 1.7%. One patient
ied of noncardiac reasons (pulmonary carcinoma), 2 pa-
ients experienced sudden cardiac death (i.e., cardiac death
ortality 0.6%/year). A 75-year-old woman died suddenly 6
onths after TASH. After a successful TASH procedure,
etrograde AV block was present and QRS duration in-
reased from 120 ms to 160 ms because of right bundle
ranch block. She developed delayed complete heart block 3
ays after TASH, received a permanent pacemaker on day
, and left the hospital on day 8. The remaining patient (74
ears, female) died suddenly 5 months after an uneventful
ASH procedure and hospital stay (QRS prolongation
rom 115 ms to 125 ms because of ethanol-induced right
undle branch block, no AV nodal conduction disturbances).
ACEMAKER DEPENDENCY IN FOLLOW-UP. We performed
acemaker interrogation in all patients at 6-month follow-up.
n 3 patients, we found permanent third-degree AV block Tfter pacemaker inhibition (2 patients received the device
fter sudden unexpected complete heart block and 1 after
ersisting intraprocedural complete heart block). According
o this, the overall permanent pacemaker dependency after 6
onths is 15%. The ventricular pacing rate in patients
ithout permanent complete heart block was 3.1  1.6% at
-month follow-up; however, the reason for ventricular
acing (sinus bradycardia or third-degree AV block) could
ot be specified. We are not able to state precisely the rate
f temporary pacemaker dependency during follow-up.
iscussion
arious patterns of conduction disturbance after the TASH
rocedure have been described (2,8–16). Disorders of AV
onduction (intraprocedural or delayed complete heart
lock) are the most frequently observed serious complications
fter alcohol ablation and lead to permanent pacemaker im-
lantation in 7% to 38% of patients (8–16). The intracardiac
ecordings obtained in our study during the onset of intra-
rocedural third-degree AV block provide strong evidence
hat the site of injury is located distal or inside the bundle of
is in most cases. The significant prolongation of the HV
nd the QRS interval after TASH in the patient group with
ntraprocedural third-degree AV block supports this hy-
othesis. Presumably, VA block after TASH also reflected
H block. Although the frequency of intraprocedural com-
lete heart block could be reduced by reducing the amount
f ethanol, the risk of delayed complete heart block remains
onstant (5). A period of telemetric monitoring up to day 8
s recommended after TASH because of the sometimes late
nd unexpected occurrence of complete heart block (10),
hich increases procedure costs. Temporary pacemakers are
outinely placed at the time of alcohol injection, but there
re no widely accepted guidelines for their management
fter the procedure. The identification of patients who are at
igh risk for delayed complete heart block after TASH is
till an unresolved issue. However, some groups identified
RS duration and/or the presence of left bundle branch
lock at baseline as a risk factor for the development of
acemaker dependency (8,12–16). Our study indicates that
he occurrence of pacemaker dependency is not rare after
ASH, even when low amounts of ethanol are used. The
acemaker implantation rate in our study population was
1.6%. For the vast majority (75%), delayed complete heart
lock was the reason for pacemaker implantation. The
roportion of delayed complete heart block after TASH was
.7% in this series. We previously published a rate of
elayed complete heart block of 3.5% in a series of 198
atients (10). Delayed complete heart block was reported in
nly 2 of 297 patients (0.8%) who were included in the
erman TASH registry (9). A recent study reported com-
lete heart block in 13 patients (25%) occurring 36  22 h
fter alcohol ablation in a series of 48 patients (16). The
ariability of subacute complete heart block reported after
ASH may be explained by different definitions of delayed
c
e
u
m
h
s
t
n
c
p
r
i
a
i
b
p
m
t
a
b
b
t
s
o
d
d
T
n
i
i
b
c
A
r
p
b
t
A
d
t
T
c
f
b
a
h
b
p
d
w
b
p
t
b
w
S
w
w
m
C
P
d
8
s
w
o
d
c
a
f
n
A
T
I
f
R
K
W
s
E
R
2362 Lawrenz et al. JACC Vol. 49, No. 24, 2007
Predictors of Complete Heart Block After TASH June 19, 2007:2356–63omplete heart block. Asymptomatic complete heart block,
specially if remaining for only a few seconds, might be
nderestimated in centers with a shorter period of telemetric
onitoring, resulting in a lower rate of delayed complete
eart block. However, the prognostic relevance of a tran-
ient complete heart block after TASH remains unclear. On
he other hand, intraprocedural differences (ethanol doses,
umber of vessels ablated, or even the presence of an EP
atheter in the His bundle position) among the centers
erforming the TASH procedure may have influenced the
ate of complete heart block.
Permanent pacemaker dependency at 6 months was low
n the group of 20 patients with a permanent pacemaker
fter TASH (3 of 20). Therefore, a watchful waiting strategy
n patients with TASH-induced complete heart block seems to
e reasonable. However, no data exist regarding temporary
acemaker dependency during follow-up. Those patients
ight be at high risk of at least syncope unless they are
reated with a permanent device. Considering the lack of
vailable data on patients with transient high-degree AV
lock after TASH and the potential risk for the patient, we
elieve that all patients with TASH-induced late complete
otal heart block should receive a permanent pacemaker for
afety reasons, even if complete heart block is transient.
In our study we identified several risk factors for the
ccurrence of complete heart block. Pre-existing conduction
isorders were associated with a higher risk of intraproce-
ural complete heart block and conduction disorders after
ASH with a higher risk of delayed block. Retrograde AV
odal block after the session and age turned out to be
ndependent risk factors for delayed heart block. A QRS
nterval prolongation and intraprocedural complete heart
lock, although associated with a higher risk of delayed
omplete heart block, did not improve the predictive power.
QRS interval prolongation at baseline and older age were
isk factors for the occurrence of an intraprocedural com-
lete heart block. All of these parameters are characterized
y high negative predictive values and low positive predic-
ive values. None of the patients with unimpaired retrograde
V nodal conduction after TASH developed pacemaker
ependency (negative predictive value 100%). Therefore,
he patient group without retrograde AV nodal block after
ASH (44%) can be considered to be at very low risk of
omplete heart block after TASH. Patients without any risk
actor (59 patients, 34%) did not develop complete heart
lock during follow-up in our study collective. Patients with
single risk factor had only a 3.5% risk of delayed complete
eart block. On the other hand, patients with retrograde
lock after TASH and at least 1 additional risk factor (53
atients, 30% of the study population) had a 26% risk of
elayed total heart block. Considering the risk associated
ith complete heart block, prolonged temporary pacemaker
ackup up to day 6 is recommended in these 30% of the
atients after TASH, which means treatment of 53 patients
o protect 14 patients from developing delayed total heartlock. Only 1 patient with delayed complete heart block
ould have been missed using this approach.
tudy limitations. Risk factors for pacemaker dependency
ere identified from the data obtained in our study. It
ould be desirable to evaluate these criteria in a prospective
ulticenter study.
onclusions
ostprocedural continuous telemetric ECG recording for 8
ays after TASH disclosed delayed complete heart block in
.7%. The EP investigation during TASH improves the
afety of the procedure by enabling identification of patients
ho are at high risk of complete heart block. The duration
f temporary pacemaker backup should be prolonged up to
ay 6 after TASH in patients who are at high risk of delayed
omplete heart block (patients with retrograde AV block
nd at least 1 additional risk factor). In the absence of risk
actors, prolonged temporary pacemaker backup is not
ecessary.
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